DAA1966 |
Alox5 arachidonate 5-lipoxygenase (5-LOX) promoter methylation increase |
Molecular |
hippocampus |
Mouse |
— |
— |
|
DAA1222 |
RELN promoter methylation increase |
Molecular |
brain, cerebral cortex |
Human |
RELN |
— |
|
DAA1224 |
MTHFR methylation decrease |
Molecular |
prefrontal cortex |
Human |
— |
— |
|
DAA1223 |
APOE promoter methylation decrease |
Molecular |
prefrontal cortex |
Human |
APOE |
— |
|
DAA2212 |
toll-like receptor 5 increases with age |
Molecular |
hippocampus |
Human |
TLR5 |
96.4% Increase Gene Expression Level |
|
DAA2265 |
NLR family, pyrin domain containing 1 decreases with age |
Molecular |
parietal lobe |
Human |
NLRP1 |
24.8% Decrease Gene Expression Level |
|
DAA2266 |
Thioredoxin interacting protein increases with age |
Molecular |
temporal lobe |
Human |
TXNIP |
146.6% Increase Gene Expression Level |
|
DAA2214 |
toll-like receptor 7 increases with age |
Molecular |
hippocampus |
Human |
TLR7 |
56.5% Increase Gene Expression Level |
|
DAA2376 |
major histocompatibility complex, class I, C increases with age |
Molecular |
hippocampus |
Human |
HLA-C |
39.8% Increase Gene Expression Level |
|
DAA2327 |
major histocompatibility complex, class I, B increases with age |
Molecular |
hippocampus |
Human |
HLA-B |
35.0% Increase Gene Expression Level |
|
DAA2230 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
parietal lobe |
Human |
MYD88 |
54.8% Increase Gene Expression Level |
|
DAA1090 |
ATP/GTP Binding Protein-like 5 |
Molecular |
frontal lobe |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA2358 |
major histocompatibility complex, class II, DQ beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DQB1 |
135.4% Increase Gene Expression Level |
|
DAA2369 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
135.3% Increase Gene Expression Level |
|
DAA2218 |
toll interacting protein decreases with age |
Molecular |
parietal lobe |
Human |
TOLLIP |
61.5% Decrease Gene Expression Level |
|
DAA2152 |
complement component 4B increases with age |
Molecular |
parietal lobe |
Human |
C4B |
444.8% Increase Gene Expression Level |
|
DAA2165 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
39.5% Increase Gene Expression Level |
|
DAA2197 |
complement component 1, s subcomponent increases with age |
Molecular |
frontal lobe |
Human |
C1S |
71.9% Increase Gene Expression Level |
|
DAA2284 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
Molecular |
parietal lobe |
Human |
FCGR2A |
141.5% Increase Gene Expression Level |
|
DAA2270 |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide increases with age |
Molecular |
temporal lobe |
Human |
FCER1G |
98.1% Increase Gene Expression Level |
|
DAA2356 |
major histocompatibility complex, class II, DP beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DPB1 |
13.2% Increase Gene Expression Level |
|
DAA2178 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
33.1% Increase Gene Expression Level |
|
DAA1420 |
programmed cell death 4 |
Molecular |
hippocampus |
Mouse |
Pdcd4 |
2.0% Increase Gene Expression Level |
|
DAA2200 |
complement factor H increases with age |
Molecular |
frontal lobe |
Human |
CFH |
210.8% Increase Gene Expression Level |
|
DAA2245 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
277.8% Increase Gene Expression Level |
|